Feedback / Questions
zabalafin hydrogel (AB-101a) - Alphyn Biologics
https://www.prnewswire.com/news-releases/alphyn-announces-first-patient-dosed-in-clear-ad1-global-phase-2b-clinical-trial-program-of-zabalafin-hydrogel-for-atopic-dermatitis-302422539.html
Apr 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next